FUJIREBIO DIAGNOSTICS CA 19-9 RIA— 510(k) K020566

Name: FDA 510(k) clearance K020566
Creator: U.S. Food and Drug Administration
Published: 2002-05-09

Substantially Equivalent

Fujirebio Diagnostics,Inc.

FDA 510(k) clearance K020566 for FUJIREBIO DIAGNOSTICS CA 19-9 RIA, Substantially Equivalent on 2002-05-09. Applicant: Fujirebio Diagnostics,Inc.. Device class: 2.

Clearance details

Applicant: Fujirebio Diagnostics,Inc.
Product code: Code NIG
Device class: Class 2
Regulation: 21 CFR 866.6010
Advisory panel: Immunology
Date received: 2002-02-20
Decision date: 2002-05-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code NIG

view all

K253528 — Atellica IM CA 19-9 II2026-08-10
K231525 — VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack2023-08-09
K200997 — Lumipulse G CA19-9-N2020-05-14
K191973 — Lumpipulse G CA19-9-N2019-10-22
K100375 — DIMENSION VISTA LOCI CA 19-9 FLEX REAGENT CARTRIDGE, AND DIMENSION LOCI7 CALIBRATOR WITH MODEL(S) K6457, AND KC6042011-04-06

More clearances from Fujirebio Diagnostics,Inc.

view all

K250925 — ADVIA Centaur Cytokeratin Fragment 21-12025-12-16
K242706 — Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio2025-05-16
DEN200072 — Lumipulse G ß-Amyloid Ratio (1-42/1-40)2022-05-04
K192524 — Lumipulse G CA15-32020-09-04
K192380 — ST AIA-PACK BNP2020-08-24

Adverse events under product code NIG

product code NIG

Malfunction: 618
Total: 618

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.